News and Announcements
Shivom Covered by CryptoCoin!
- Published April 15, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- CryptoCoin covers Shivom, offering a review of the company
- This feature shares information on Shivom’s panel of experts on board, insights about the OmiX token, partnerships, use of blockchain and its position among the noteworthy blockchain projects.
A leading news source for information on cryptocurrencies, ICO reviews, cryptonews, and blockchain projects, CryptoCoin.com has recently covered Shivom.
The article, offers a review of Shivom and its goal to build the world’s largest genomic data-hub and healthcare ecosystem; its new and unique global healthcare OmiX token, and its scope of improving precision medicine, DNA data analysis, and prognosis of various diseases using genomic data.
Throwing light on various aspects of Shivom as a DNA data-hub, a potential global health game-changer, and major new cryptocurrency project, the article presents a holistic view of Shivom’s capability and its prospects in the ICO market and as a driver of healthcare as it strategically integrates blockchain technology with DNA Data.
The article is a must-read for anyone who wants to be further informed about Shivom, the panel of experts on board, insights about the OmiX token, partnerships, use of blockchain and its position among the noteworthy blockchain projects.
An excerpt from the article states, “Shivom ecosystem will function in a decentralized way by using blockchain technologies, integrating the best protocols for advanced encryption and the combination of this with Artificial Intelligence.”
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
